Adaptive Biotechnologies Corporation (ADPT) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Adaptive Biotechnologies (ADPT) management is effectively developing immunological platforms while striving to optimize costs. Tracking the business valuation via EV/EBITDA helps determine the company's recovery pace, while 0.00 reflects the latest value of this metric. High-demand diagnostic tests ensure a steady cash flow. Revenue is generated through B2B contracts with medical centers to develop treatments for infections and cancer.
adaptivebiotech.com - analytical breakdowns and key metrics (ADPT)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
Debt to Equity Adaptive Biotechnologies|ADPT - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Adaptive Biotechnologies Corporation|ADPT - Company Cumulative Debt|Debts to Book Capitalization Adaptive Biotechnologies Inc.|ADPT - Company Long-Term Debts|Company Short-Term Debts Adaptive Biotechnologies|Quick Ratio adaptivebiotech.com
- business earnings and investment ratios data:
ADPT - Net Profit|Expected Profit Adaptive Biotechnologies|ADPT - Market Cap to Net Income|Projected Price to Earnings Adaptive Biotechnologies|ADPT - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Adaptive Biotechnologies Inc.|ADPT - Operating income before deduction of amortization|Net earnings per share for the last 12 months Adaptive Biotechnologies|ADPT - Earnings per share for the last twelve months|Quarterly EPS earnings growth adaptivebiotech.com|ADPT - Earnings per share growth rate in current year|Expected earnings per share growth for next year Adaptive Biotechnologies
Initial company analysis:Adaptive Biotechnologies Corp ADPT
The EV/EBITDA multiple determines the total value of the business relative to its operating profit before interest and taxes, reflecting the actual payback period of the assets. By analyzing the EV/EBITDA valuation trend for Adaptive Biotechnologies (ADPT), an investor can see how the company's strategic partnerships in AI diagnostics and immunopharmaceuticals impact market capitalization and the efficiency of debt load management.
Competitors of Adaptive Biotechnologies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celldex Therapeutics (CLDX)|auriniapharma.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - Company Value to EBITDA|Dianthus Pharma - EV/EBITDA Multiple|PHVS - EV/EBITDA Multiple|ABCL: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation TRML|PGEN (Precigen) - EV/EBITDA Multiple|EV/EBITDA Multiple Pharming Group NV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nektar (NKTR)|UPB: Company Value to Operating Income Before Depreciation Ratio|Zenas Biopharma Inc - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio IMNM (immunome.com)|Gossamer Bio - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio KalVista Pharma KALV|SEPN (Septerna Corp) - Enterprise Value to EBITDA Ratio|PVLA (Pieris Corp) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SVRA (Savara Inc.) - EV/EBITDA Multiple|Company Value to EBITDA rigel.com RIGL|Enterprise Value to EBITDA Ratio ANAB (AnaptysBio)|ATXS (Astria Therapeutics Inc) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ENGN (enGene Bio)|rapt.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Aerovate - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio aclaristx.com ACRS|Kyverna Therapeutics, Inc. (KYTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Tiziana Life Sciences Ltd. (TLSA)|Enterprise Value to EBITDA Ratio CABA|VTYX (Ventyx Biosciences, Inc) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple THTX|AVTX - Company Value to EBITDA|EV/EBITDA Multiple ELDN (Eledon Pharmaceuticals, Inc.)|AGEN - Enterprise Value to EBITDA Ratio|Climb Bio, Inc. - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation ZURA (zurabio.com)|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ADAG|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ImageneBio|Company Value to EBITDA Shattuck Therapeutics STTK|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium, Inc. (EQ)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CNTB (connectbiopharm.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic IMUX|Atara Biotherapeutics, Inc. (ATRA) - Company Value to EBITDA|InflaRx GmbH - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple X4 Pharmaceuticals Inc. (XFOR)|ACET: EV/EBITDA Multiple|CELU - Total Company Value to Operating Income Before Depreciation Ratio|INMB (INmune Bio, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA barinthusbio.com BRNS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|Total Company Value to Operating Income Before Depreciation Ratio SAB Biotherapeutics Inc.|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|EV/EBITDA Multiple Enlivex Therapeutics Ltd ENLV|Q32 Bio Corp - EV/EBITDA Multiple|GOVX (geovax.com) - Enterprise Value to Operating Income Before Depreciation|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio IBIO (iBio Inc)|Enterprise Value to EBITDA Ratio CARM|XTLB (XTL Bio) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|HCWB: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|Business Value to Operating Income Before Depreciation AIM|Aditxt Corp - EV/EBITDA Multiple|GRI - EV/EBITDA Multiple|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|reshapelifesciences.com - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences, Inc.|Enterprise Value to EBITDA Ratio Indaptus Therapeutics Inc (INDP)|EV/EBITDA Multiple SCNI|EV/EBITDA Multiple calcimedica.com (CALI)|Affimed N.V. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ALLK|HOOKIPA - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IGM Biosciences, Inc. IGMS|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Ocean Biomedical Corp|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|Enterprise Value to EBITDA Ratio thirdharmonicbio.com (THRD)
